Long‐Term Recurrence‐Free Survival After Surgery and Adjuvant Furmonertinib in a Patient With EGFR‐Mutated Pulmonary Sarcomatoid Carcinoma: A Case Report
ABSTRACT Background Pulmonary sarcomatoid carcinoma (PSC) is an extremely rare subtype of non‐small cell lung cancer (NSCLC), which generally shows limited response to chemoradiotherapy and confers poor overall survival (OS). Recent progress in molecular targeted therapy has provided potential therapeutic strategies fo...